Rapid Medical Diagnostics Market Share,Size,Forecast 2019-2026

SKU: DMD382 | Last Updated On: 2019-08-16 | No. of Pages: 228 | Available Formats

( 38 Samples have been requested. )
May 2, 2019 - Abbott announced that its m-PIMA™ HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, had received the World Health Organization's Prequalification approval (WHO PQ). The test received the CE Mark in December 2018.

Rapid Medical Diagnostics Market

The global Rapid Medical Diagnostics market was worth $XX billion in 2018 and is forecasted to reach $XX billion by 2026, at a CAGR of XX% during the forecast period.

Rapid Medical Diagnostic tests are diagnostic assays designed for use at the point-of-care (POC) which can be adapted for use in low-resource settings. An RDT is low-cost, simple to operate and read, sensitive, specific, stable at high temperatures, and works in a short period of time. These tests are intended to provide diagnostic results conveniently and immediately to the patient while still at the health facility, screening site, or other health care provider.

Global Rapid Medical Diagnostics Market Dynamics

The Global Market for Rapid Medical Diagnostics is driven by the increasing prevalence of cardiovascular and gastrointestinal disorders, STDs and other lifestyle disorders such as diabetes, rising trend towards on-site diagnosis in the US, improvements in technology and increasing awareness combined with low rates of diagnosis of diseases such as Hepatitis and TB along with improvement in healthcare availability in emerging markets.

The rise of lifestyle disorders such as obesity has resulted in a significant increase in the number of cardiovascular and other disorders. Over 422 million people globally are estimated to be affected by diabetes, with a significant portion remaining undiagnosed. Increasing awareness of such disorders in emerging markets is expected to drive the demand for rapid diagnostic kits.

H. pylori is one of the most common bacterial infections in humans, affecting nearly 50% of the world’s population and it has been associated with the development of serious upper gastrointestinal (GI) conditions including chronic gastritis, peptic ulcer disease, gastric cancer, and mucosa-associated lymphoid tissue (MALT). The reduction in cost and rising availability of rapid diagnostic tests for the infection is expected to increase demand for diagnostic kits.

The market is also being driven by the improvements in technology leading to higher sensitivity, wider coverage and lower costs which is driving the adoption of these tests.

The Global market for Rapid Medical Diagnostics is restrained by the low sensitivity of current methods, stringent regulations and reduction in reimbursed costs through medic-aid in the USA.

The most common technology used for rapid medical diagnosis is LFIA. This technology has a relatively lower rate of sensitivity compared to clinical ELISA machines leading to greater false positives for diseases. This has led to stricter regulations and warnings from the WHO and the US FDA. The market is also affected by the cutback in Medicaid reimbursement due to budgetary constraints in the US.

Global Rapid Medical Diagnostics Market – Segment Analysis

Based on product the global market for Rapid Medical Diagnostics is broadly segmented as – By Technology, By Type and By End-User

By Technology, the global market for rapid medical diagnostics is segmented into Lateral Flow immunoassays, Agglutination assays, Flow-Through immunoassays, Solid-Phase assays (Dipsticks) and microfluidic chips. The global market for rapid diagnostic tests is led by lateral flow immunoassays (LFIA) due to their low development costs and ease of production. However, the LFIA technology tends to have lower sensitivity compared to other methods. Microfluidic chips are expected to be the fastest growing segment during the forecast period due to their potential to provide a fully integrated POC device for sample processing, fluid handling, and signal generation.

By Type, The Global Market for Rapid Medical Diagnostics is segmented into Infectious Diseases, Toxicology, Gastrointestinal and Cardiac disorders and Others. The Global Market is led by Infectious Disease diagnostics. This is due to the higher prevalence of these diseases relative to other disorders along with their continuous evolution which necessitates response leading to higher demand. A prime example of this trend can be seen from the rise of the Zika virus, which led to a sharp increase in demand for diagnostic kits in the segment.

By End-User, The Global Market for Rapid Medical Diagnostics is segmented into Hospitals, Clinics and Self-care. The global market is led by hospitals and clinics*[1] due to the preparation process required for these tests. Clinics are expected to be the fastest growing segment during the forecast period due to the growing trend towards decentralisation of healthcare combined with the relative ease of use and speed of these tests.

Global Rapid Medical Diagnostics Market – Geographical Analysis

The global rapid medical diagnostics market is segmented into North America, Europe, Asia Pacific, South America and Middle-East and Africa.

North America dominates the global market for rapid medical diagnostics by revenue due to its excellent healthcare infrastructure combined with high awareness and a large population base. The market is expected to grow slowly or remain flat due to reductions in healthcare spending and insurance reimbursement.

Asia-Pacific is expected to be the fastest growing market in the projected timeframe due to improvement in healthcare infrastructure combined with increasing disposable incomes and rising awareness. The region’s large population combined with under-penetration of medical technologies is expected to drive demand in the projected timeframe. Key players expect the region to be their growth driver with the Chinese market being the prime source of demand.

Global Rapid Medical Diagnostics Market – Competitive Analysis

The market for rapid medical diagnostics is highly fragmented overall due to the simplicity of development and manufacture of the technology involved leading to intense competition in major segments such as malaria diagnosis. Due to the breadth of the market, most companies don’t cover the entire spectrum of diagnosis with Abbott Laboratories being a prime exception. Individual market segments have companies holding large or even majority market shares; for instance, AccessBio Inc holds the majority market share in the malaria diagnosis segment. The industry is highly competitive and is innovating rapidly through investments in new technologies such as the microfluidic chips. Significant R&D expenditure is also being directed to expand the disease detection capabilities of the products.

Key players in the market are merging or acquiring other players, increasing R&D spending and launching new products. The market is consolidating with many large players such as Alere being acquired by giant healthcare corporations such as Abbott Laboratories. These developments are in line with the general trend of consolidation seen through the healthcare industry.

List of major market players –

  • Abbot Laboratories
  • Bio-Rad Laboratories
  • AccessBio Inc.
  • AccuBioTech Co. Ltd.
  • Quidel Corporation
  • Meridian Bioscience Inc.
  • OraSure Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • Becton Dickinson and Co.
  • Trinity Biotech Plc.

Recent News –

May 2, 2019 - Abbott announced that its m-PIMA™ HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, had received the World Health Organization's Prequalification approval (WHO PQ). The test received the CE Mark in December 2018.

February 20, 2019 - Abbott announced that it had received the CE Mark for the world's most sensitive rapid diagnostic test for the detection of hepatitis B surface antigen, the Determine™ HBsAg 2 test for use with serum, plasma or whole blood.

February 07, 2019 - DiabetOmics launched its Lumella rapid POC test for Preeclampsia Assessment. Lumella provides an accurate and reliable estimate of Glycosylated Fibronectin (GlyFN) - a protein biomarker that is elevated in pregnant women with a high risk for developing Preeclampsia.

December 18, 2018 - Quidel received the CE Mark for Point-of-Care Sofia® 2 Lyme+ Fluorescent Immunoassay for Use with Sofia 2 Instrument.

Key Takeaways

  • Rapid Medical Diagnostic tests are diagnostic assays designed for use at the point-of-care (POC) which can be adapted for use in low-resource settings
  • The Global Market for Rapid Medical Diagnostics is driven by the increasing prevalence of cardiovascular and gastrointestinal disorders, STDs and other lifestyle disorders such as diabetes, rising trend towards on-site diagnosis in the US, improvements in technology and increasing awareness combined with low rates of diagnosis of diseases such as Hepatitis and TB along with improvement in healthcare availability in emerging markets
  • Based on product the global market for Rapid Medical Diagnostics is broadly segmented as – By Technology, By Type and By End-User
  • The market for rapid medical diagnostics is highly fragmented overall due to the simplicity of development and manufacture of the technology involved leading to intense competition in major segments. Key players in the market are merging or acquiring other players, increasing R&D spending and launching new products.

Why Purchase the Report?

  • Visualize the composition of the Rapid Medical Diagnostic market across each indication, in terms of type and treatment options, highlighting the key commercial assets and players.
  • Identify commercial opportunities in Rapid Medical Diagnostic market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of the Rapid Medical Diagnostic market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key products of all major market players

Target Audience:

  • Equipment Suppliers/ Buyers
  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

[1] Excluding Glucose Monitoring Devices.

Global Rapid Medical Diagnostics Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  1. Global Rapid Medical Diagnostics Market – Market Definition and Overview
  2. Global Rapid Medical Diagnostics Market – Executive Summary
    1. Market Snippet by Condition
    2. Market Snippet by Technology
    3. Market Snippet by Type
    4. Market Snippet by End-Users
    5. DataM CLO Scenario
  3. Global Rapid Medical Diagnostics Market – Market Dynamics
    1. Market Impacting Factors
      1. Drivers
        1. Increasing prevalence of Cardiovascular, GI and other lifestyle disorders.
        2. Advances in Technology
        3. Increasing awareness in emerging markets
      2. Restraints
        1. Decreasing Medicaid Reimbursements in the US.
      3. Impact Analysis
  4. Global Rapid Medical Diagnostics Market – Industry Analysis
    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Regulatory Analysis
    4. Pricing Analysis
    5. Technology Advances
    6. Key Companies to Watch
    7. Epidemiology

Global Rapid Medical Diagnostics Market – By Technology

    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    3. Market Attractiveness Index, By Technology
    4. Lateral Flow Immunoassays.
      1. Introduction
      2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    5. Flow-Through Immunoassays
    6. Solid Phase Assays
    7. Agglutination Assays
    8. Microfluidic Chips
  1. Global Rapid Medical Diagnostics Market – By Type
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    3. Market Attractiveness Index, By Type
    4. Infectious Diseases
      1. Introduction
      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
    5. Toxicology
    6. Cardiovascular and Gastrointestinal disorders
    7. Others
  2. Global Rapid Medical Diagnostics Market – By End-Users
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
    3. Market Attractiveness Index, By End-Users
    4. Hospitals
      1. Introduction
      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
    5.               Clinics
    6. Self-Care
  3. Global Rapid Medical Diagnostics Market – By Region
    1. Introduction
    2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    3. Market Attractiveness Index, By Region
    4. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. U.S.
        2. Canada
        3. Mexico
    5. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    6. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    7. Asia-Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    8. Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
  4. Global Market – Competitive Landscape
    1.          Competitive Scenario
    2. Comparative Product Portfolio Analysis
    3. Market Positioning/Share Analysis
    4. Mergers and Acquisitions Analysis
  5. Company Profiles
    1. Abbot Laboratories
      1. Company Overview
      2. Product Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Bio-Rad Laboratories
    3. AccessBio Inc.
    4. AccuBioTech Co. Ltd.
    5. Quidel Corporation
    6. Meridian Bioscience Inc.
    7. OraSure Technologies, Inc.
    8. ThermoFisher Scientific Inc.
    9. Becton Dickinson and Co.
    10. Trinity Biotech Plc.
  6. Global Rapid Medical Diagnostics Market – Premium Insights
  7. Global Rapid Medical Diagnostics Market – DataM
    1. Appendix
    2. About Us and Services
    3. Contact Us

Table 1 Global Rapid Medical Diagnostics Market Value, By Technology, 2018,2022 & 2026 ($ Million)

Table 2 Global Rapid Medical Diagnostics Market Value, By Type, 2018,2022 & 2026 ($ Million)

Table 3 Global Rapid Medical Diagnostics Market Value, By End-Users, 2018,2022 & 2026 ($ Million)

Table 4 Global Rapid Medical Diagnostics Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 5 Global Rapid Medical Diagnostics Market Value, By Technology, 2018,2022 & 2026 ($ Million)

Table 6 Global Rapid Medical Diagnostics Market Value, By Technology, 2017-2026 ($ Million)

Table 7 Global Rapid Medical Diagnostics Market Value, By Type, 2018,2022 & 2026 ($ Million)

Table 8 Global Rapid Medical Diagnostics Market Value, By Type, 2017-2026 ($ Million)

Table 9 Global Rapid Medical Diagnostics Market Value, By End-Users, 2018,2022 & 2026 ($ Million)

Table 10 Global Rapid Medical Diagnostics Market Value, By End-Users, 2017-2026 ($ Million)

Table 11 Global Rapid Medical Diagnostics Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 12 Global Rapid Medical Diagnostics Market Value, By Region, 2017-2026 ($ Million)

Table 13 North America Rapid Medical Diagnostics Market Value, By Technology, 2017-2026 ($ Million)

Table 14 North America Rapid Medical Diagnostics Market Value, By Type, 2017-2026 ($ Million)

Table 15 North America Rapid Medical Diagnostics Market Value, By End-Users, 2017-2026 ($ Million)

Table 16 North America Rapid Medical Diagnostics Market Value, By Country, 2017-2026 ($ Million)

Table 17 South America Rapid Medical Diagnostics Market Value, By Technology, 2017-2026 ($ Million)

Table 18 South America Rapid Medical Diagnostics Market Value, By Type, 2017-2026 ($ Million)

Table 19 South America Rapid Medical Diagnostics Market Value, By End-Users, 2017-2026 ($ Million)

Table 20 South America Rapid Medical Diagnostics Market Value, By Country, 2017-2026 ($ Million)

Table 21 Europe Rapid Medical Diagnostics Market Value, By Technology, 2017-2026 ($ Million)

Table 22 Europe Rapid Medical Diagnostics Market Value, By Type, 2017-2026 ($ Million)

Table 23 Europe Rapid Medical Diagnostics Market Value, By End-Users, 2017-2026 ($ Million)

Table 24 Europe Rapid Medical Diagnostics Market Value, By Country, 2017-2026 ($ Million)

Table 25 Asia-Pacific Rapid Medical Diagnostics Market Value, By Technology, 2017-2026 ($ Million)

Table 26 Asia-Pacific Rapid Medical Diagnostics Market Value, By Type, 2017-2026 ($ Million)

Table 27 Asia-Pacific Rapid Medical Diagnostics Market Value, By End-Users, 2017-2026 ($ Million)

Table 28 Asia-Pacific Rapid Medical Diagnostics Market Value, By Country, 2017-2026 ($ Million)

Table 29 Middle East & Africa Rapid Medical Diagnostics Market Value, By Technology, 2017-2026 ($ Million)

Table 30 Middle East & Africa Rapid Medical Diagnostics Market Value, By Type, 2017-2026 ($ Million)

Table 31 Middle East & Africa Rapid Medical Diagnostics Market Value, By End-Users, 2017-2026 ($ Million)

Table 32 Abbot Laboratories: Overview

Table 33 Abbot Laboratories: Product Portfolio

Table 34 Abbot Laboratories: Key Developments

Table 35 Bio-Rad Laboratories: Overview

Table 36 Bio-Rad Laboratories: Product Portfolio

Table 37 Bio-Rad Laboratories: Key Developments

Table 38 AccessBio Inc.: Overview

Table 39 AccessBio Inc.: Product Portfolio

Table 40 AccessBio Inc.: Key Developments

Table 41 AccuBioTech Co. Ltd.: Overview

Table 42 AccuBioTech Co. Ltd.: Product Portfolio

Table 43 AccuBioTech Co. Ltd.: Key Developments

Table 44 Quidel Corp.: Overview

Table 45 Quidel Corp.: Product Portfolio

Table 46 Quidel Corp.: Key Developments

Table 47 Meridian Bioscience Inc.: Overview

Table 48 Meridian Bioscience Inc.: Product Portfolio

Table 49 Meridian Bioscience Inc.: Key Developments

Table 50 OraSure Technologies Inc.: Overview

Table 51 OraSure Technologies Inc.: Product Portfolio

Table 52 OraSure Technologies Inc.: Key Developments

Table 53 ThermoFisher Scientific Inc.: Overview

Table 54 ThermoFisher Scientific Inc.: Product Portfolio

Table 55 ThermoFisher Scientific Inc.: Key Developments

Table 56 Becton Dickinson and Co.: Overview

Table 57 Becton Dickinson and Co.: Product Portfolio

Table 58 Becton Dickinson and Co.: Key Developments

Table 59 Trinity Biotech Plc.: Overview

Table 60 Trinity Biotech Plc.: Product Portfolio

Table 61 Trinity Biotech Plc.: Key Developments
Figure 1 Global Rapid Medical Diagnostics Market Share, By Technology, 2018 & 2026 (%)

Figure 2 Global Rapid Medical Diagnostics Market Share, By Type, 2018 & 2026 (%)

Figure 3 Global Rapid Medical Diagnostics Market Share, By End-Users, 2018 & 2026 (%)

Figure 4 Global Rapid Medical Diagnostics Market Share, By Region, 2018 & 2026 (%)

Figure 5 Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 6 Global Rapid Medical Diagnostics Market Y-o-Y Growth, By Technology, 2018-2026 (%)

Figure 7 Lateral Flow Immunoassays: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 8 Flow-Through Immunoassays: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 9 Solid Phase Assays: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 10 Agglutination Assays: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 11 Microfluidic Chips: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 12 Global Rapid Medical Diagnostics Market Y-o-Y Growth, By Type, 2018-2026 (%)

Figure 13 Infectious Diseases: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 14 Toxicology: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 15 Cardiovascular and GI disorders: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 16 Others: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 17 Global Rapid Medical Diagnostics Market Y-o-Y Growth, By End-Users, 2018-2026 (%)

Figure 18 Hospitals: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 19 Clinics: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 20 Self-Use: Global Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 21 Global Rapid Medical Diagnostics Market Y-o-Y Growth, By Region, 2018-2026 (%)

Figure 22 North America Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 23 North America Rapid Medical Diagnostics Market Share, By Technology, 2018 & 2026 (%)

Figure 24 North America Rapid Medical Diagnostics Market Share, By Type, 2018 & 2026 (%)

Figure 25 North America Rapid Medical Diagnostics Market Share, By End-Users, 2018 & 2026 (%)

Figure 26 North America Rapid Medical Diagnostics Market Share, By Country, 2018 & 2026 (%)

Figure 27 South America Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 28 South America Rapid Medical Diagnostics Market Share, By Technology, 2018 & 2026 (%)

Figure 29 South America Rapid Medical Diagnostics Market Share, By Type, 2018 & 2026 (%)

Figure 30 South America Rapid Medical Diagnostics Market Share, By End-Users, 2018 & 2026 (%)

Figure 31 South America Rapid Medical Diagnostics Market Share, By Country, 2018 & 2026 (%)

Figure 32 Europe Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 33 Europe Rapid Medical Diagnostics Market Share, By Technology, 2018 & 2026 (%)

Figure 34 Europe Rapid Medical Diagnostics Market Share, By Type, 2018 & 2026 (%)

Figure 35 Europe Rapid Medical Diagnostics Market Share, By End-Users, 2018 & 2026 (%)

Figure 36 Europe Rapid Medical Diagnostics Market Share, By Country, 2018 & 2026 (%)

Figure 37 Asia-Pacific Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 38 Asia-Pacific Rapid Medical Diagnostics Market Share, By Technology, 2018 & 2026 (%)

Figure 39 Asia-Pacific Rapid Medical Diagnostics Market Share, By Type, 2018 & 2026 (%)

Figure 40 Asia-Pacific Rapid Medical Diagnostics Market Share, By End-Users, 2018 & 2026 (%)

Figure 41 Asia-Pacific Rapid Medical Diagnostics Market Share, By Country, 2018 & 2026 (%)

Figure 42 Middle East & Africa Rapid Medical Diagnostics Market Value, 2017-2026 ($ Million)

Figure 43 Middle East & Africa Rapid Medical Diagnostics Market Share, By Technology, 2018 & 2026 (%)

Figure 44 Middle East & Africa Rapid Medical Diagnostics Market Share, By Type, 2018 & 2026 (%)

Figure 45 Middle East & Africa Rapid Medical Diagnostics Market Share, By End-Users, 2018 & 2026 (%)

Figure 46 Abbot Laboratories: Financials 

Figure 47 Bio-Rad Laboratories: Financials 

Figure 48 AccessBio Inc.: Financials 

Figure 49 AccuBioTech Co. Ltd.: Financials 

Figure 50 Quidel Corp.: Financials 

Figure 51 Meridian Bioscience Inc.: Financials 

Figure 52 OraSure Technologies Inc.: Financials 

Figure 53 ThermoFisher Scientific Inc.: Financials 

Figure 54 Becton Dickinson and Co.: Financials 

Figure 55 Trinity Biotech Plc.: Financials 

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report